The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2022Pharmacokinetics, Food Effects, Safety and Tolerability of Aggregation Inhibitor Anle138b in Parkinson´s Disease
Study Rationale:
Pathological alpha-synuclein aggregates, called Lewy bodies, are a hallmark of Parkinson’s disease (PD) and a promising target for therapeutics. Anle138b is a compound that inhibits... -
Fall 2021 RFA: Promoting Diversity, Equity and Inclusion in Parkinson’s Disease Research, 2022Preventing Fractures in Parkinson’s Disease by Identifying Barriers to Care and Social Determinants of Health
Study Rationale: Compared with the general population, people with Parkinson’s disease (PD) are more likely to fall and break a bone as a result of disease-related motor issues, such as difficulty...
-
Outcome Measures, 2022Improving the generalizability and robustness of MRI-derived biomarkers of Parkinson's Disease through analytical and data variability evaluations
Study Rationale: Medical imaging is a promising technique to help with the early diagnosis, understanding, and treatment of Parkinson's disease. Indeed, using advanced image acquisition techniques and...
-
Fall 2021 RFP: Outcome Measures, 2022Using RNA from Extracellular Vesicles to Monitor RNA Changes in the Brain
Study Rationale: Our understanding of Parkinson’s disease (PD) would be significantly improved if we had a way to directly monitor disease development and progression in the brain. One approach is to...
-
Diversity, Equity and Inclusivity in Parkinson's research, 2022Understanding the Progression of Motor and Non-motor Symptoms and Functional Mobility of Māori and Pacific Peoples in New Zealand
Study Rationale: In this study, we will work with two underrepresented groups in Aotearoa, New Zealand, the Māori and Pacific peoples. By better understanding the clinical presentation of Parkinson’s...
-
Fall 2021 RFP: Outcome Measures, 2022Development of Standardized Measurements for Monitoring the Progression of Parkinson’s Disease via MRI
Study Rationale: One of the difficulties in research towards new treatments in Parkinson’s disease (PD) is the diversity of disease presentations and the lack of tools to measure the effect of a...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.